NIFTY 50▲24,213.30
217.95 (0.91%)
SENSEX▲79,476.63
694.39 (0.88%)
NIFTY BANK▲52,207.25
992.00 (1.94%)
TATA MOTORS▲835.65
11.55 (1.40%)
SUZLON ENERGY▲67.37
1.05 (1.58%)
TATA STEEL▲152.29
5.34 (3.63%)
INDIAN RAILWAY FINANCE CORP▼151.44
-1.80 (-1.17%)
TATA POWER▲434.10
5.05 (1.18%)
RAIL VIKAS NIGAM▲450.90
4.70 (1.05%)
RELIANCE INDUSTRIES▲1,305.30
3.15 (0.24%)
VODAFONE IDEA▲8.14
0.26 (3.30%)
ZOMATO▼241.87
-3.21 (-1.31%)
RELIANCE POWER▼41.52
-0.51 (-1.21%)
INDIAN RENEWABLE ENERGY▼204.77
-0.61 (-0.30%)
ADANI POWER▲603.45
18.45 (3.15%)
YES BANK▲20.62
0.29 (1.43%)
STATE BANK OF INDIA▲849.20
19.35 (2.33%)
NHPC▼80.18
-3.12 (-3.75%)
HDFC BANK▲1,757.85
43.75 (2.55%)
OLA ELECTRIC MOBILITY LTD▼74.18
-6.66 (-8.24%)
JIO FIN SERVICES LTD▲321.90
2.05 (0.64%)
INDIAN OIL CORP▲140.80
1.87 (1.35%)
BHARAT ELECTRONICS▲286.35
2.20 (0.77%)
GTL INFRA▲2.20
0.09 (4.27%)
MRF▼1,19,530.15
-1346.60 (-1.11%)
ADANI PORT & SEZ▼1,329.35
-19.90 (-1.47%)
JAIPRAKASH POWER VENTURES▲17.96
0.08 (0.45%)
ITC▼480.20
-4.40 (-0.91%)
- Aarti Pharmalabs
Aarti Pharmalabs Share Price
AARTIPHARM
₹660.70+₹10.30 (1.58%) TodayLast updated on 05 Nov, 2024 | 15:47 IST
Aarti Pharmalabs Share Price Chart
Please wait...
About Aarti Pharmalabs
Aarti Pharmalabs Financials
Market cap  ₹5,894 Crs | Open ₹648.75 | Close ₹650.40 |
Circuit range ₹780.45 - ₹520.35 | Day range ₹642.35 - ₹668.00 | Year range ₹380.05 - ₹721.70 |
Volume 3,65,757 | Avg. traded ₹660.03 | Revenue (12m) ₹1,968 Crs |
Aarti PharmalabsAarti Pharmalabs Limited is a manufacturer of active pharmaceutical ingredients (API), pharmaceutical intermediates, new chemical entities (NCE), xanthine derivatives, and allied products, situated in India. The Company delivers contract development and manufacturing organization (CDMO) services for drug substance/NCE development and manufacturing for pharmaceutical and biotech firms with a focus on the Ph-I/II/III, launch, and commercial phases. It has dedicated facilities for the production of corticosteroids, cytotoxic medicines, and oncology products. Its range of API products include Ramipril, Quinapril HCL, Budesonide, Bambuterol HCL, Apixaban, Rivaroxaban, Cinacalcet and others. Its range of intermediate products include Abemaciclib Intermediate, Acalabrutinib Intermediate, Afatinib Intermediate, Apalutamide Intermediate, Azathioprine Intermediate, and others. Its Caffeine products include caffeine anhydrous, and caffeine anhydrous (granules).
Aarti Pharmalabs Key indicators
52 week high ₹721.70 | 52 week low ₹380.05 | P/E ratio 25.85 |
P/B ratio 2.97 | ROE 13.11% | ROCE 16.55% |
Dividend yield 0.5% | Debt/Equity ratio 0.15 | EPS 22.14 |
Learn more
Featured in
Investment checklist: (2/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Aarti Pharmalabs Fundamentals
Aarti Pharmalabs Financial Ratios
Operating profit margin23.78% | Net profit margin13.36% |
ROE13.11% | ROA9.39% |
ROCE16.55% |
Learn more
Aarti Pharmalabs Shareholder returns
1 day | 1 week | 1 month |
3 months | 1 year | 3 years |
5 years |
Aarti Pharmalabs Share Price history
| Day | Open | Close | Change % |
|---|---|---|---|
Mon, Nov 4 2024 | ₹647.60 | ₹650.40 | |
Fri, Nov 1 2024 | ₹646.90 | ₹642.50 | |
Thu, Oct 31 2024 | ₹622.95 | ₹639.55 | |
Wed, Oct 30 2024 | ₹610.90 | ₹622.50 | |
Tue, Oct 29 2024 | ₹624.70 | ₹608.85 | -3.72% |
Mon, Oct 28 2024 | ₹609.75 | ₹632.35 | |
Fri, Oct 25 2024 | ₹612.00 | ₹605.40 | -2.50% |
Thu, Oct 24 2024 | ₹594.95 | ₹620.95 |
Aarti Pharmalabs Shareholding Pattern
Promoters (46.1%) | Mutual Funds (4.93%) | Retail and other (35.16%) |
Foreign institutions-FII (7.38%) | Other domestic institutions (6.43%) |
Promoters
Learn more
Events
Corporate actions
Dividend • ₹1/share
Ex date 31 Jul 2024
Dividend • ₹2/share
Ex date 16 Feb 2024
Dividend • ₹2/share
Ex date 17 Jan 2023
Learn more
More
People also bought
Aarti Pharmalabs News
